Jonsson Comprehensive Cancer Center
🇺🇸United States
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
Phase 1
Recruiting
- Conditions
- Stage IVA Prostate Cancer AJCC v8Metastatic Prostate CarcinomaStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
- Interventions
- Procedure: Image Guided Biopsy
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05398302
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
Phase 1
Recruiting
- Conditions
- Metastatic HER2-Positive Breast CarcinomaPrognostic Stage IB Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8
- Interventions
- Other: Quality-of-Life Assessment
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT05319873
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Phase 1
Recruiting
- Conditions
- Diffuse Large B-Cell LymphomaHigh-grade B-cell LymphomaTransformed LymphomaSecondary Central Nervous System Lymphoma
- Interventions
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT05256641
- Locations
- 🇺🇸
University of Oklahoma, Oklahoma City, Oklahoma, United States
🇺🇸UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
Early Phase 1
Recruiting
- Conditions
- Prostate Carcinoma
- Interventions
- Procedure: Biopsy of ProstateOther: Gallium Ga 68 GozetotideProcedure: Transrectal Ultrasonography Guided Biopsy
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05160597
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy
Not Applicable
Recruiting
- Conditions
- Locally Advanced Head and Neck Carcinoma
- Interventions
- Dietary Supplement: Dietary SupplementOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT05115760
- Locations
- 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma
Early Phase 1
Recruiting
- Conditions
- Recurrent GliomaRecurrent Malignant GliomaGliomaMalignant Glioma
- Interventions
- Procedure: Biospecimen CollectionProcedure: Diagnostic ImagingProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT05045027
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors
Early Phase 1
Withdrawn
- Conditions
- Survivors of Childhood Cancer
- Interventions
- Behavioral: text messaging intervention
- First Posted Date
- 2021-08-11
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT05000359
- Locations
- 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
Not Applicable
Recruiting
- Conditions
- Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8
- Interventions
- Radiation: High-Dose Rate BrachytherapyRadiation: Stereotactic Body Radiation Therapy
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 52
- Registration Number
- NCT04945642
- Locations
- 🇺🇸
University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy
Phase 2
Terminated
- Conditions
- Stage IVA Prostate Cancer AJCC v8Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IVB Prostate Cancer AJCC v8
- Interventions
- Procedure: Computed TomographyOther: Gallium Ga 68 GozetotideProcedure: Positron Emission Tomography
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2022-10-21
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 22
- Registration Number
- NCT04928820
- Locations
- 🇺🇸
University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy
Phase 2
Recruiting
- Conditions
- Stage IIIC Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
- Interventions
- Radiation: Stereotactic Body Radiation Therapy
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 102
- Registration Number
- NCT04915508
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath